# EDGAR Filing Document

**Accession Number:** 0000047071
**File Stem:** 0001580642-23-000957
**Filing Date:** 2023-2
**Character Count:** 67039
**Document Hash:** 842fb2c03a8fdd90bf2da1ba014ef0ad
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001580642-23-000957.hdr.sgml**: 20230221

**ACCESSION NUMBER**: 0001580642-23-000957

**CONFORMED SUBMISSION TYPE**: N-CSRS

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230221

**DATE AS OF CHANGE**: 20230221

**EFFECTIVENESS DATE**: 20230221

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BRUCE FUND INC
- **CENTRAL INDEX KEY:** 0000047071
- **IRS NUMBER:** 066104682
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** N-CSRS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-01528
- **FILM NUMBER:** 23647855

**BUSINESS ADDRESS:**
- **STREET 1:** 20 N WACKER DR
- **STREET 2:** STE 2414
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606
- **BUSINESS PHONE:** 3122369160

**MAIL ADDRESS:**
- **STREET 1:** 20 N WACKER DR
- **STREET 2:** STE 2414
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEROLD FUND INC
- **DATE OF NAME CHANGE:** 19831114

## Series and Classes Contracts Data

### BRUCE FUND (Series ID: S000011411)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000031584 | BRUCE FUND   | BRUFX           |

**united states<br> securities and exchange commission<br> washington, d.c. 20549<br>form n-csr<br>certified shareholder report of registered management<br> investment companies**

Investment Company Act file number <u>811-01528</u> 

<u>Bruce Fund, Inc.</u> 

(Exact name of registrant as specified in charter)

<u>20 North Wacker Drive, Suite 2414 Chicago, IL 60606</u> 

(Address of principal executive offices) (Zip code)

R. Jeffrey Bruce

Bruce & Co.

20 North Wacker Drive, Suite 2414

Chicago, IL 60606

(Name and address of agent for service)

Registrant's telephone number, including area code: <u>312-236-9160</u> 

Date of fiscal year end: <u>6/30</u> 

Date of reporting period: <u>12/31/2022</u> 

Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

**Item 1. Reports to Stockholders.** 

(a) 2022

BRUCE FUND, INC.

SEMI-ANNUAL

REPORT

Report to Shareholders

*December 31, 2022*

20 North Wacker Drive ● Suite 2414 ● Chicago, Illinois 60606 ● (312) 236-9160

**Management's Discussion of Fund Performance (Unaudited)**

The Bruce Fund (the "Fund") shares produced a total return of 2.65% for the six months ended December 31, 2022, compared to a total return of 2.31% for the S&P 500<sup>®</sup> Index for the same period. Stock markets rebounded slightly in the period and the Fund did as well. Government bond prices in the portfolio declined in the six month period as well as our corporate bonds. Overall the Fund's equities created the gains in the period.

Monetary measures taken over the last decade have encouraged risk and excess. The market is repricing that risk and we continue to see a difficult period. The Fund has raised cash in an attempt to address the risks. Given the excessive debt levels and geopolitical, economic and policy uncertainties, we feel our caution is warranted. Valuations for some companies show reasonable long-term opportunities but even there, we believe a more conservative posture is warranted.

Management continues to screen investment opportunities for their long-term capital appreciation potential versus the risks that investment might present. The bonds as well as the stocks in the portfolio encompass significant investment risks, which are outlined in the prospectus.

Shareholders are invited to use the toll-free number (800) 872-7823 to obtain any Fund information (including the proxy voting record), or can visit www.thebrucefund.com, to obtain the same.

**Investment Results (Unaudited)**

**Average Annual Total Returns for the Periods Ended December 31, 2022**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Fund/Index** | **Six Months** | **1 Year** | **5 Year** | **10 Year** |
| **Bruce Fund** | 2.65% | (8.76)% | 7.12% | 8.67% |
| **S&P 500<sup>®</sup> Index\*** | 2.31% | (18.11)% | 9.42% | 12.56% |

---

The net expense ratio as of the most recent prospectus dated October 28, 2022 was 0.69%. Additional information pertaining to the Fund's expense ratios as of December 31, 2022 can be found in the financial highlights.

***The performance quoted represents past performance, which does not guarantee future results.*** The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. The returns shown do not reflect deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Current performance of the Fund may be lower or higher than the performance quoted. The Fund's investment objectives, risks, charges and expenses must be considered carefully before investing. Performance data current to the most recent month end may be obtained by calling l-800-872-7823. Total returns for periods less than one year are not annualized.

\* The S&P 500<sup>®</sup> Index (the "Index") is an unmanaged index that assumes reinvestment of all distributions and excludes the effect of taxes and fees. The Index is a widely recognized unmanaged index of equity prices and is representative of a broader market and range of securities than is found in the Fund's portfolio. Individuals cannot invest directly in the Index; however, an individual can invest in exchange-traded funds or other investment vehicles that attempt to track the performance of a benchmark index.

***The Fund is distributed by Ultimus Fund Distributors, LLC, member FINRA/SIPC.***

**Fund Holdings (Unaudited)**

![(BAR CHART)](bc001_v1.jpg)

<sup>1</sup> As a percent of net assets.

**Investment Objective**

The investment objective of the Bruce Fund is long-term capital appreciation.

**Availability of Portfolio Schedule**

This Fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission ("SEC") for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The Fund's Form N-PORT reports are available on the SEC's website at www.sec.gov or on the Fund's website at www.thebrucefund.com.

---

| |
|:---|
| **Bruce Fund** |
| **Schedule of Investments (Unaudited)** |
| *December 31, 2022* |

---

---

| | | |
|:---|:---|:---|
| | **Shares** | **Fair Value** |
| **COMMON STOCKS — 64.2%** |  |  |
| **Communications — 4.4%** |  |  |
| AT&T, Inc. | 1050000 | $19330500 |
| Sirius XM Holdings, Inc. | 657843 | 3841803 |
|  |  | 23172303 |
| **Energy — 0.0%<sup>(a)</sup>** |  |  |
| PetroQuest Energy, Inc.<sup>(b) (c) (d)</sup> | 2834246 | 14171 |
| **Financials — 3.9%** |  |  |
| Allstate Corp. (The) | 150000 | 20340000 |
| **Health Care — 24.1%** |  |  |
| 908 Devices, Inc.<sup>(d)</sup> | 68286 | 520339 |
| Abbott Laboratories | 154500 | 16962555 |
| AbbVie, Inc. | 180000 | 29089800 |
| Amryt Pharma PLC - ADR (United Kingdom)<sup>(d)</sup> | 315182 | 2300829 |
| Bausch Health Cos., Inc. (Canada)<sup>(d)</sup> | 800000 | 5024000 |
| EDAP TMS SA - ADR (France)<sup>(d)</sup> | 529794 | 5647604 |
| Fate Therapeutics, Inc.<sup>(d)</sup> | 57000 | 575130 |
| IGM Biosciences, Inc.<sup>(d)</sup> | 55000 | 935550 |
| LAVA Therapeutics N.V. (Netherlands)<sup>(d)</sup> | 100000 | 350000 |
| MannKind Corp.<sup>(d)</sup> | 195073 | 1028035 |
| Merck & Co., Inc. | 280000 | 31066000 |
| Organon & Co. | 30000 | 837900 |
| Paratek Pharmaceuticals, Inc.<sup>(d)</sup> | 1427412 | 2669260 |
| Personalis, Inc.<sup>(d)</sup> | 50000 | 99000 |
| Pfizer, Inc. | 500000 | 25620000 |
| Supernus Pharmaceuticals, Inc.<sup>(d)</sup> | 92105 | 3285385 |
| Viatris, Inc. | 55835 | 621444 |
|  |  | 126632831 |
| **Industrials — 8.5%** |  |  |
| Insteel Industries, Inc. | 274000 | 7540480 |
| U-Haul Holding Co., Class B | 600000 | 32988000 |
| U-Haul Holding Co. | 68000 | 4092920 |
|  |  | 44621400 |
| **Materials — 0.9%** |  |  |
| Ashland Global Holdings, Inc. | 15000 | 1612950 |
| Newmont Corp. | 65600 | 3096320 |
|  |  | 4709270 |
| **Technology — 1.3%** |  |  |
| Apple, Inc. | 55000 | 7146150 |

---

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Schedule of Investments (Unaudited) (continued)** |
| *December 31, 2022* |

---

---

| | | |
|:---|:---|:---|
| | **Shares** | **Fair Value** |
| **COMMON STOCKS — (continued)** |  |  |
| **Utilities — 21.1%** |  |  |
| Avista Corp. | 200000 | $8868000 |
| CMS Energy Corp. | 400000 | 25332000 |
| Duke Energy Corp. | 250000 | 25747500 |
| NextEra Energy, Inc. | 310000 | 25916000 |
| Xcel Energy, Inc. | 360000 | 25239600 |
|  |  | 111103100 |
| *Total Common Stocks (Cost $183,511,458)* |  | 337739225 |
|  | **Principal** |  |
|  | **Amount** |  |
| **U.S. GOVERNMENT BONDS — 4.3%** |  |  |
| U.S. Treasury "Strips", 0.00%, 2/15/2036 | $20000000 | 12394105 |
| U.S. Treasury "Strips", 0.00%, 2/15/2041 | 10000000 | 4937144 |
| U.S. Treasury "Strips", 0.00%, 5/15/2049 | 15000000 | 5343210 |
| *Total U.S. Government Bonds (Cost $25,042,808)* |  | 22674459 |
| **CONVERTIBLE CORPORATE BONDS — 3.9%** |  |  |
| **Health Care — 3.9%** |  |  |
| Accelerate Diagnostics, Inc., 2.50%, 3/15/2023 | 3000000 | 2776875 |
| Acorda Therapeutics, Inc., 6.00%, 12/1/2024 | 5000000 | 3749847 |
| Novavax, Inc., 3.75%, 2/1/2023 | 600000 | 598140 |
| Paratek Pharmaceuticals, Inc., 4.75%, 5/1/2024 | 15000000 | 13188000 |
| Synergy Pharmaceuticals, Inc., 7.50%, 11/1/2019<sup>(b) (c) (e) (f)</sup> | 1500000 | 150 |
| *Total Convertible Corporate Bonds (Cost $23,362,252)* |  | 20313012 |

---

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Schedule of Investments (Unaudited) (continued)** |
| *December 31, 2022* |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Fair Value** |
| **MONEY MARKET FUNDS — 27.5%** |  |  |
| Morgan Stanley Institutional Liquidity Government Portfolio, Institutional Class, 4.11%<sup>(g)</sup> | 144963219 | $144963219 |
| *Total Money Market Funds (Cost $144,963,219)* |  | 144963219 |
| *Total Investments — 99.9% (Cost $376,879,737)* |  | 525689915 |
| *Other Assets in Excess of Liabilities — 0.1%* |  | 622751 |
| *NET ASSETS — 100.0%* |  | $526312666 |

---

(a) Rounds
 to less than 0.05%.

(b) Security
 is currently being valued according to the fair value procedures approved by the Board of Directors.

(c) Illiquid
 security. The total fair value of these securities as of December 31, 2022 was $14,321, representing 0.0% of net assets.

(d) Non-income
 producing security.

(e) Security
 exempt from registration under Rule 144A or Section 4(2) of the Securities Act of 1933. The security may be resold in transactions
 exempt from registration, normally to qualified institutional buyers. The total fair value of these securities as December 31, 2022
 was $150, representing 0.0% of net assets.

(f) In
 default.

(g) Rate
 disclosed is the seven day effective yield as of December 31, 2022.

ADR – American Depositary Receipt

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Statement of Assets and Liabilities (Unaudited)** |
| *December 31, 2022* |

---

---

| | |
|:---|:---|
| **Assets** | |
| Investments in securities, at market value (cost $376,879,737) | $525689915 |
| Dividends and interest receivable | 1175974 |
| Receivable for fund shares sold | 3500 |
| Prepaid expenses | 17129 |
| **Total Assets** | 526886518 |
| **Liabilities** |  |
| Payable for investments purchased | 138054 |
| Payable for fund shares redeemed | 90305 |
| Accrued investment advisory fees | 241081 |
| Payable to Administrator | 42948 |
| Payable to trustees | 5203 |
| Other accrued expenses | 56261 |
| **Total Liabilities** | 573852 |
| **Net Assets** | $526312666 |
| **Net Assets consist of** |  |
| Capital stock (976,277 shares of $1 par value capital stock issued and outstanding) | 976277 |
| Paid-in capital | 367898347 |
| Accumulated earnings | 157438042 |
| **Net Assets** | $526312666 |
| **Shares outstanding: 2,000,000 shares authorized** | 976277 |
| **Net asset value, offering and redemption price per share** | $539.10 |

---

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Statement of Operations (Unaudited)** |
| *For the six months ended December 31, 2022* |

---

---

| | |
|:---|:---|
| **Investment Income** |  |
| Dividend income | $6691555 |
| Interest income | 1725033 |
| **Total investment income** | 8416588 |
| **Expenses** |  |
| Investment advisory | 1409412 |
| Administration | 132051 |
| Transfer agent | 63909 |
| Fund accounting | 49059 |
| Audit and tax preparation | 32651 |
| Custodian | 23417 |
| Registration | 18545 |
| Postage | 10468 |
| Printing | 9648 |
| Director | 5203 |
| Insurance | 769 |
| Other | 4047 |
| **Net operating expenses** | 1759179 |
| **Net investment income** | 6657409 |
| **Net Realized and Change in Unrealized Gain (Loss) on Investments** |  |
| Net realized gain on investment securities | 22033600 |
| Change in unrealized appreciation (depreciation) on investment securities | (14944253) |
| **Net realized and change in unrealized gain on investments** | 7089347 |
| **Net increase in net assets resulting from operations** | $13746756 |

---

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Statements of Changes in Net Assets** |

---

---

| | | |
|:---|:---|:---|
|  | **For the** | |
|  | **Six Months Ended** | **For the** |
|  | **December 31, 2022** | **Year Ended** |
|  | **(Unaudited)** | **June 30, 2022** |
| **Increase (Decrease) in Net Assets due to:** |  |  |
| **Operations** |  |  |
| Net investment income | $6657409 | $8629670 |
| Net realized gain on investment securities | 22033600 | 46619805 |
| Change in unrealized appreciation (depreciation) on investment securities | (14944253) | (80840066) |
| Net increase (decrease) in net assets resulting from operations | 13746756 | (25590591) |
| **Distributions to Shareholders from** |  |  |
| Earnings | (62472852) | (51809231) |
| **Total distributions** | (62472852) | (51809231) |
| **Capital Transactions** |  |  |
| Proceeds from shares sold | 2898911 | 6837742 |
| Reinvestment of distributions | 57662249 | 48313650 |
| Amount paid for shares redeemed | (13359833) | (40055669) |
| **Net increase in net assets resulting from capital transactions** | 47201327 | 15095723 |
| **Total Decrease in Net Assets** | (1524769) | (62304099) |
| **Net Assets** |  |  |
| Beginning of period | 527837435 | 590141534 |
| **End of period** | $526312666 | $527837435 |
| **Share Transactions** |  |  |
| Shares sold | 4947 | 10241 |
| Shares issued in reinvestment of distributions | 107996 | 73479 |
| Shares redeemed | (22694) | (59902) |
| **Net increase in shares outstanding** | 90249 | 23818 |

---

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Financial Highlights** |
| *Selected data for each share of capital stock outstanding through each period is presented below* |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **For the** | | | | | |
|  | **Six Months** | | | | | |
|  | **Ended** | | | | | |
|  | **December 31,** | | | | | |
|  | **2022** | **For the Year Ended June 30,** | **For the Year Ended June 30,** | **For the Year Ended June 30,** | **For the Year Ended June 30,** | **For the Year Ended June 30,** |
|  | **(Unaudited)** | **2022** | **2021** | **2020** | **2019** | **2018** |
| **Selected Per Share Data** |  |  |  |  |  |  |
| **Net asset value, beginning of period** | $595.73 | $684.45 | $559.92 | $555.00 | $522.54 | $522.91 |
| Investment operations: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income | 7.74 | 10.16 | 12.24 | 13.36 | 11.64 | 12.71 |
| &nbsp;&nbsp;&nbsp;Net realized and unrealized gain (loss) | 7.38 | (36.91) | 148.70 | 3.58 | 33.09 | 8.52 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total from investment operations | 15.12 | (26.75) | 160.94 | 16.94 | 44.73 | 21.23 |
| Less distributions to shareholders from: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income | (13.09) | (9.75) | (13.58) | (12.02) | (12.27) | (11.69) |
| &nbsp;&nbsp;&nbsp;Net realized gains | (58.66) | (52.22) | (22.83) |  |  | (9.91) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total distributions | (71.75) | (61.97) | (36.41) | (12.02) | (12.27) | (21.60) |
| **Net asset value, end of period** | $539.10 | $595.73 | $684.45 | $559.92 | $555.00 | $522.54 |
| **Total Return**<sup>(a)</sup>** | 2.65 % <sup>(b)</sup> | (4.76)% | 29.42% | 2.96% | 8.81% | 4.01% |
| **Ratios and Supplemental Data:** |  |  |  |  |  |  |
| Net assets, end of period ($ millions) | $526.31 | $527.84 | $590.14 | $501.20 | $520.58 | $533.96 |
| Ratio of expenses to average net assets | 0.67 % <sup>(c)</sup> | 0.66% | 0.66% | 0.67% | 0.67% | 0.67% |
| Ratio of net investment income to average net assets | 2.52 % <sup>(c)</sup> | 1.49% | 1.84% | 2.28% | 2.08% | 2.31% |
| Portfolio turnover rate | 3 % <sup>(b)</sup> | 6% | 4% | 15% | 7% | 20% |

---

<sup>(a)</sup> Total return represents the rate that the investor would have earned or lost on an investment in the Fund, assuming reinvestment of distributions.

<sup>(b)</sup> Not annualized.

<sup>(c)</sup> Annualized.

*See accompanying notes which are an integral part of these financial statements.*

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited)** |
| *December 31, 2022* |

---

**NOTE A – ORGANIZATION**

Bruce Fund, Inc. (the "Fund") is a Maryland corporation incorporated on June 20, 1967. The Fund is registered under the Investment Company Act of 1940, as amended ("1940 Act"), as an open end diversified management investment company and the Fund's primary investment objective is long-term capital appreciation. The investment adviser to the Fund is Bruce & Co., Inc. (the "Adviser").

**NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Basis of Preparation** – The Fund is an investment company and follows accounting and reporting guidance under Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic 946, "Financial Services-Investment Companies". The following is a summary of significant accounting policies followed by the Fund in preparation of its financial statements. These policies are in conformity with the generally accepted accounting principles in the United States of America ("GAAP").

**Estimates** – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.

**Securities Valuation** – All investments in securities are recorded at their fair value as described in Note C.

**Federal Income Taxes** – The Fund makes no provision for federal income or excise tax. The Fund has qualified and intends to qualify each year as a regulated investment company ("RIC") under subchapter M of the Internal Revenue Code of 1986, as amended, by complying with the requirements applicable to RICs and by distributing substantially all of its taxable income. The Fund also intends to distribute sufficient net investment income and net capital gains, if any, so that it will not be subject to excise tax on undistributed income and gains. If the required amount of net investment income or gains is not distributed, the Fund could incur a tax expense.

As of and during the six months ended December 31, 2022, the Fund did not have a liability for any unrecognized tax benefits. The Fund recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the statement of operations. During the period, the Fund did not incur any interest or penalties.

**Security Transactions and Related Income** – Investment transactions are accounted for no later than the first calculation of the Net Asset Value ("NAV") on the business day following the trade date. For financial reporting purposes, however, security transactions are accounted for on the trade date on the last business day of the reporting period. The specific identification method is used for determining gains or losses for financial statements

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

and income tax purposes. Dividend income is recorded on the ex-dividend date and interest income is recorded on an accrual basis. Discounts and premiums on securities purchased are accreted or amortized using the effective interest method. Withholding taxes on foreign dividends have been provided for in accordance with the Fund's understanding of the applicable country's tax rules and rates. The ability of issuers of debt securities held by the Fund to meet their obligations may be affected by economic and political development in the relevant specific country or region.

**Distributions** – Distributions to shareholders, which are determined in accordance with income tax regulations, are recorded on the ex-dividend date. The Fund intends to distribute substantially all of its net investment income as dividends and distributions to its shareholders on at least an annual basis. The Fund intends to distribute its net realized long-term capital gains and its net realized short-term capital gains at least once a year. The treatment for financial reporting purposes of distributions made to shareholders during the year from net investment income or net realized capital gains may differ from their ultimate treatment for federal income tax purposes. These differences are caused primarily by differences in the timing of the recognition of certain components of income, expenses or realized capital gain for federal income tax purposes. Where such differences are permanent in nature, they are reclassified in the components of the net assets based on their ultimate characterization for federal income tax purposes. Any such reclassifications will have no effect on net assets, results of operations or net asset values per share of the Fund.

**NOTE C – SUMMARY OF SECURITIES VALUATION AND FAIR VALUE MEASUREMENTS**

In accordance with Accounting Standards Codification 820, "Fair Value Measurements and Disclosures" ("ASC 820"), fair value is defined as the price that the Fund would receive upon selling an investment in an orderly transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of the observable market data and minimize the use of unobservable inputs and to establish classification of the fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk (the risk inherent in a particular valuation technique used to measure fair value such as pricing model and/or the risk inherent in the inputs to the valuation technique). Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity's own

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

assumptions about the assumptions market participants would use in pricing the asset or liability, developed based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad levels listed below:

● Level 1 – unadjusted quoted prices in active markets for identical investments and/ or registered investment companies where the value per share is determined and published and is the basis for current transactions for identical assets or liabilities at the valuation date

● Level 2 – other significant observable inputs (including, but not limited to, quoted prices for an identical security in an inactive market, quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)

● Level 3 – significant unobservable inputs (including the Fund's own assumptions in determining fair value of investments based on the best information available)

The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

Equity securities, including common stocks, convertible preferred stocks, and American Depositary Receipts (ADR's), are generally valued by using market quotations, but may be valued on the basis of prices furnished by a pricing service when the Adviser believes such prices more accurately reflect the fair value of such securities. Securities that are traded on any stock exchange are generally valued by the pricing service at the last quoted sale price. Lacking a last sale price, an exchange traded security is generally valued by the pricing service at its last bid price. Securities traded in the NASDAQ over-the-counter market are generally valued by the pricing service at the NASDAQ Official Closing Price. When using market quotations or close prices provided by the pricing service and when the market is considered active, the security will be classified as a Level 1 security. Sometimes, an equity security owned by the Fund will be valued by the pricing service with factors other than market quotations or when the market is considered inactive. When this happens, the security will be classified as a Level 2 security.

When market quotations are not readily available, when the Adviser determines that the market quotation or the price provided by the pricing service does not accurately reflect the current fair value, or when restricted or illiquid securities are being valued, such securities are valued as determined by the Adviser, in conformity with guidelines adopted by and subject to review by the Board of Directors (the "Board"). These securities are generally categorized as Level 3 securities.

Investments in mutual funds, including money market mutual funds, are generally priced at the ending NAV provided by the service agent of the funds. These securities will be categorized as Level 1 securities.

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

Fixed income securities, including corporate bonds, convertible corporate bonds, U.S. government bonds, and U.S. municipal bonds are generally categorized as Level 2 securities and valued on the basis of prices furnished by a pricing service. A pricing service uses various inputs and techniques, which include broker-dealer quotations, live trading levels, recently executed transactions in securities of the issuer or comparable issuers, and option adjusted spread models that include base curve and spread curve inputs. Adjustments to individual bonds can be applied to recognize trading differences compared to other bonds issued by the same issuer. The broker-dealer quotations received are supported by credit analysis of the issuer that takes into consideration credit quality assessments, daily trading activity, and the activity of the underlying equities, listed bonds and sector-specific trends. To the extent that these inputs are observable, the fixed income securities are categorized as Level 2 securities. If the Adviser decides that a price provided by the pricing service does not accurately reflect the fair value of the securities, when prices are not readily available from a pricing service, or when restricted or illiquid securities are being valued, securities are valued at fair value as determined in good faith by the Adviser, in conformity with guidelines adopted by and subject to review of the Board. These securities are generally categorized as Level 3 securities.

The following is a summary of the inputs used to value the Fund's investments as of December 31, 2022, based on the three levels defined previously:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Communications | $23172303 | $— | $— | $23172303 |
| &nbsp;&nbsp;&nbsp;Energy |  |  | 14171 | 14171 |
| &nbsp;&nbsp;&nbsp;Financials | 20340000 |  |  | 20340000 |
| &nbsp;&nbsp;&nbsp;Health Care | 126632831 |  |  | 126632831 |
| &nbsp;&nbsp;&nbsp;Industrials | 44621400 |  |  | 44621400 |
| &nbsp;&nbsp;&nbsp;Materials | 4709270 |  |  | 4709270 |
| &nbsp;&nbsp;&nbsp;Technology | 7146150 |  |  | 7146150 |
| &nbsp;&nbsp;&nbsp;Utilities | 111103100 |  |  | 111103100 |
| U.S. Government Bonds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. Treasury Strips |  | 22674459 |  | 22674459 |
| Convertible Corporate Bonds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Health Care |  | 20312862 | 150 | 20313012 |
| Money Market Funds | 144963219 |  |  | 144963219 |
| &nbsp;&nbsp;&nbsp;Total | $482688273 | $42987321 | $14321 | $525689915 |

---

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

In the absence of a listed price quote, or in the case of a supplied price quote which is deemed to be unrepresentative of the actual market price, the Adviser shall use any or all of the following criteria to value Level 3 securities:

● Last sales price

● Price given by pricing service

● Last quoted bid & asked price

● Third party bid & asked price

● Indicated opening range

● Estimated remaining distributions

● Estimated possible recoveries

The significant unobservable inputs that may be used in the fair value measurement of the Fund's investments in common stock, corporate bonds and convertible corporate bonds for which market quotations are not readily available include: broker quotes, discounts from the most recent trade or "stale price" and estimates from trustees (in bankruptcies) on disbursements. A change in the assumption used for each of the inputs listed above may indicate a directionally similar change in the fair value of the investment.

The following provides quantitative information about the Fund's significant Level 3 fair value measurements as of December 31, 2022:

**Quantitative Information about Significant Level 3 Fair Value Measurements**

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**Asset Category** | **Fair Value at**<br>**December 31,**<br>**2022** | <br>**Valuation**<br>**Techniques** | <br>**Unobservable Input(s)** |<br>**Range** |
| Common Stocks | $14171 | Asset Liquidation Analysis | Liquidation Proceeds | N/A |
| Convertible Corporate Bonds | 150 | Asset Liquidation Analysis | Liquidation Proceeds | N/A |

---

Following is a reconciliation of assets in which significant unobservable inputs (Level 3) were used in determining fair value for the Fund:

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>**Balance as of**<br>**June 30, 2022** |<br>**Realized gain**<br>**(loss)** | **Change in**<br>**unrealized**<br>**appreciation**<br>**(depreciation)** |<br><br>**Purchases** |
| Common Stock | $15471 | $26130 | $(1300) | $— |
| Convertible Corporate Bonds | 150 |  |  |  |
| &nbsp;&nbsp;&nbsp;Total | $15621 | $26130 | $(1300) | $— |

---

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| |<br>**Sales** |<br>**Transfer in**<br>**Level 3\*<sup>(a)</sup>** |<br>**Transfer out**<br>**Level 3\*<sup>(b)</sup>** | **Balance as of**<br>**December 31,**<br>**2022** |
| Common Stock | $(26130) | $— | $— | $14171 |
| Convertible Corporate Bonds |  |  |  | 150 |
| &nbsp;&nbsp;&nbsp;Total | $(26130) | $— | $— | $14321 |

---

\* The amount of transfers in and/or out are reflected at the reporting period end.

<sup>(a)</sup> Transfers in relate primarily to securities for which observable inputs became unavailable during the period. Therefore, the securities were valued at fair value by the Adviser, in conformity with guidelines adopted by and subject to review by the Board and are categorized as Level 3 inputs as of December 31, 2022.

<sup>(b)</sup> Transfers out relate primarily to securities for which observable inputs became available during the period, and as of December 31, 2022, the Fund was able to obtain quotes from its pricing service. These quotes represent Level 2 inputs, which is the level of the fair value hierarchy in which these securities are included as of December 31, 2022.

The total change in unrealized appreciation included in the Statement of Operations attributable to Level 3 investments still held at December 31, 2022 was as follows:

---

| | |
|:---|:---|
| | **Total Change in**<br>**Unrealized Appreciation**<br>**(Depreciation)** |
| Common Stock | $(1300) |
| Convertible Corporate Bonds |  |
| Total | $(1300) |

---

**NOTE D – PURCHASES AND SALES OF SECURITIES**

For the six months ended December 31, 2022, cost of purchases and proceeds from maturities and sales of securities, other than short-term investments and short-term U.S. Government obligations were as follows:

---

| | | |
|:---|:---|:---|
| |<br>**Other** | **U.S.**<br>**Government**<br>**Obligations** |
| Purchases | $13468702 | $— |
| Sales | $64188174 | $4890000 |

---

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

**NOTE E – RELATED PARTIES**

Bruce & Co., Inc., an Illinois corporation, is the investment adviser of the Fund and furnishes investment advice. In addition, it provides office space and facilities and pays the cost of all prospectuses and financial reports (other than those mailed to current shareholders). Compensation to the Adviser for its services under the Investment Advisory Contract is paid monthly based on the following:

---

| | |
|:---|:---|
| **Annual Percentage Fee** | **Applied to Average Net Assets of Fund** |
| 1.00% | Up to $20,000,000; plus |
| 0.60% | $20,000,000 to $100,000,000; plus |
| 0.50% | over $100,000,000 |

---

At December 31, 2022, Robert B. Bruce was the beneficial owner of 25,190 Fund shares, R. Jeffrey Bruce was the beneficial owner of 31,518 Fund shares, Robert DeBartolo was the beneficial owner of 32 Fund shares, and W. Martin Johnson was the beneficial owner of 6 Fund shares. Robert B. Bruce, Robert DeBartolo, and W. Martin Johnson are directors of the Fund; both Robert B. Bruce and R. Jeffrey Bruce are officers of the Fund and the Adviser. R. Jeffrey Bruce is the majority owner of the Adviser.

Ultimus Fund Solutions, LLC ("Ultimus") provides administration, fund accounting and transfer agency services to the Fund. The Fund pays Ultimus fees in accordance with the agreements for such services. In addition, the Fund pays out-of-pocket expenses including, but not limited to, postage, supplies and certain costs related to the pricing of the Fund's portfolio securities.

Under the terms of a Distribution Agreement with the Trust, Ultimus Fund Distributors, LLC (the "Distributor") serves as the principal underwriter to the Fund. The Distributor is a wholly-owned subsidiary of Ultimus. The Distributor is compensated by the Adviser (not the Fund) for acting as principal underwriter.

**NOTE F – FEDERAL INCOME TAXES**

At December 31, 2022, the breakdown of net unrealized appreciation and tax cost of investments for federal income tax purpose is as follows:

---

| | |
|:---|:---|
| Gross Unrealized Appreciation | $173993099 |
| Gross Unrealized Depreciation | (25253705) |
| Net Unrealized Appreciation on Investments | $148739394 |
| Tax Cost | $376950521 |

---

The difference between book basis and tax basis of unrealized appreciation (depreciation) is primarily attributable to differences due to wash sales.

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

At June 30, 2022, the Fund's most recent fiscal year end, the components of distributable earnings (accumulated losses) on a tax basis were as follows:

---

| | |
|:---|:---|
| Undistributed Ordinary Income | $4757217 |
| Undistributed Long-Term Capital Gains | 37723274 |
| Unrealized Appreciation | 163683647 |
| Total | $206164138 |

---

The tax character of distributions paid during the fiscal year ended June 30, 2022 was follows:

---

| | |
|:---|:---|
|  | **2022** |
| Distributions paid from: |  |
| &nbsp;&nbsp;&nbsp;Ordinary Income | $9778094 |
| &nbsp;&nbsp;&nbsp;Long-Term Capital Gain | 42031137 |
| Total | $51809231 |

---

**NOTE G – RESTRICTED SECURITIES**

The Fund has acquired securities, the sale of which is restricted, through private placement. At December 31, 2022, the aggregate market value of such securities listed below amounted to $150, or 0.0% of the Fund's net assets. 100% of the restricted securities are valued according to fair value procedures approved by the Board. It is possible that the estimated value may differ significantly from the amount that might ultimately be realized in the near term, and the difference could be material.

The chart below shows the restricted securities held by the Fund as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**Issuer Description** | **Acquisition**<br>**Date** | **Principal**<br>**Amount** |<br>**Cost** |<br>**Value** |
| **Convertible Corporate Bonds** |  |  |  |  |
| Synergy Pharmaceuticals, Inc., 7.50%, 11/1/19 | 3/4/15 | $1500000 | $702290 | $150 |

---

**NOTE H – SECTOR RISK**

If the Fund has significant investments in the securities of issuers within a particular sector, any development affecting that sector will have a greater impact on the value of the net assets of the Fund than would be the case if the Fund did not have significant investments in that sector. In addition, this may increase the risk of loss in the Fund and increase the volatility of the Fund's NAV per share. For instance, economic or market factors, regulatory changes or other developments may negatively impact all companies in a particular sector, and therefore the value of the Fund's portfolio will be adversely affected. As of December 31, 2022, the Fund had 28.0% of the value of its net assets invested in stocks within the Health Care sector.

---

| |
|:---|
| **Bruce Fund** |
| **Notes to the Financial Statements (Unaudited) (continued)** |
| *December 31, 2022* |

---

**NOTE I – COMMITMENTS AND CONTINGENCIES**

The Fund indemnifies its officers and Board for certain liabilities that may arise from their performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into contracts that contain a variety of representations and warranties which provide general indemnifications. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred.

**NOTE J – SUBSEQUENT EVENTS**

In accordance with GAAP, management has evaluated subsequent events through the date these financial statements were issued. Based upon this evaluation, management has determined there were no items requiring adjustment of the financial statements or additional disclosure.

**Shareholder Expense Example (Unaudited)**

As a shareholder of the Fund, you incur ongoing costs, including management fees and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds. The example is based on an investment of $1,000 invested at the beginning of the period (July 1, 2022) and held for the entire period (through December 31, 2022).

**Actual Expenses**

The first line of the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = $8.60), then multiply the result by the number in the first line under the heading "Expenses Paid During the Period" to estimate the expenses you paid on your account during this period.

**Hypothetical Example for Comparison Purposes**

The second line of the table below provides information about hypothetical account values and hypothetical expenses based on the Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as redemption fees. Therefore, the second line of the table is useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different funds.

---

| | | | |
|:---|:---|:---|:---|
|  | <br>**Beginning**<br>**Account Value,** | <br>**Ending**<br>**Account Value,** | **Expenses**<br>**Paid During**<br>**the Period<sup>(a)</sup>** |
|  | <br>**July 1, 2022** | <br>**December 31, 2022** | **July 1 -**<br>**December 31, 2022** |
| Actual | $1000.00 | $1026.50 | $3.42 |
| Hypothetical<sup>(b)</sup> | $1000.00 | $1021.83 | $3.41 |

---

<sup>(a)</sup> Expenses are equal to the Fund's six-month annualized expense ratio of 0.67%, multiplied by the average account value over the period, multiplied by (184/365) (to reflect the partial year period).

 

<sup>(b)</sup> Assumes a 5% annual return before expenses.

**Approval of Management Agreement (Unaudited)**

The Board of Directors of Bruce Fund, Inc. (the "Board" or "Directors") oversees the management of the Fund and, as required by law, considered the renewal of the Investment Advisory Contract with its investment adviser, Bruce & Company, Inc. (the "Adviser").

The Board requested and evaluated all information that the Directors deemed reasonably necessary under the circumstances in connection with the renewal of the Investment Advisory Contract.

At a meeting held on August 24, 2022, the Board reviewed and discussed materials with regard to the Investment Advisory Contract between the Fund and the Adviser, which included information provided by the Adviser. At the meeting, the Board interviewed certain executives of the Adviser. After discussion, the Directors, including the Directors who are not "interested persons" (as that term is defined in the Investment Company Act of 1940) of the Fund or the Adviser (the "Independent Directors"), approved the continuance of the Investment Advisory Contract between the Fund and the Adviser for an additional year. The Directors' approval of the continuance of the Fund's investment advisory contract was based on a consideration of all the information provided to the Directors, and was not the result of any single factor. Some of the factors that figured particularly in the Directors' deliberations are described below, although individual Directors may have evaluated this information differently, ascribing different weights to various factors.

A discussion was held concerning the Fund's excellent performance and low overhead costs versus other like funds and its general financial condition.

&nbsp;&nbsp;&nbsp;&nbsp;(i) The
Nature, Extent and Quality of Services. The Directors reviewed and considered information regarding the nature, extent, and quality of
services that Bruce & Co., Inc. provides to the Fund, which include, but are not limited to, providing a continuous investment program
for the Fund, adhering to the Fund's investment restrictions, complying with the Fund's policies and procedures, and voting
proxies on behalf of the Fund. The Directors considered the qualifications and experience of the Fund's portfolio managers who
are responsible for the day-to-day management of the Fund's portfolio, as well as the qualifications and experience of other resources
utilized by Bruce & Co. to provide services to the Fund. The Directors concluded that they were satisfied with the nature, extent,
and quality of investment management services provided by Bruce & Co. to the Fund and that the fees for the services provided seem
reasonable and appropriate for the services especially in comparison to what other funds pay.

&nbsp;&nbsp;&nbsp;&nbsp;(ii) Fund
Performance. The Directors next reviewed and discussed the Fund's performance for periods ended June 30, 2022. The Directors observed
that the Fund had outperformed the median of its Morningstar Allocation - 70% to 85% category and the median for its peer group for the
one-year, three-year, five-year and since inception periods. The Directors noted that the Fund has performed better in difficult market
conditions and that longer-term assessment is appropriate. Based upon the foregoing, the Directors concluded the Fund's performance
is acceptable.

**Approval of Management Agreement (Unaudited) (continued)**

&nbsp;&nbsp;&nbsp;&nbsp;(iii) Fee
Rate and Profitability. The Directors reviewed a fee and expense comparison for the Fund. The Directors noted that the advisory fee of
the Fund is below the average and median of the Fund's Morningstar category and the Fund's peer group. The Directors also
noted that the expense ratio of the Fund is below the average and median of the Fund's Morningstar category and the Fund's
peer group.

The Directors also considered a profitability analysis the Fund prepared by Bruce & Co., which showed that Bruce & Co. is earning a profit. The Directors noted Bruce & Co.'s representation that it does not enter into soft-dollar transactions on behalf of the Fund. The Directors concluded that the management fee represents reasonable compensation in light of the nature and quality of Bruce & Co.'s services to the Fund.

The Directors considered that the Adviser bears a substantial portion of operational costs. They noted that the Adviser has been diligent to ensure that the Fund has provided no undue compensation or benefits to the Adviser or anyone else.

&nbsp;&nbsp;&nbsp;&nbsp;(iv) Economies
of Scale. In determining the reasonableness of the management fee, the Trustees also considered the extent to which Bruce & Co. will
realize economies of scale as the Fund grows. The Directors noted that the management fee is currently subject to breakpoints and that
such breakpoints are reasonable.

**Liquidity Risk Management Program (Unaudited)**

The Fund has adopted and implemented a written liquidity risk management program (the "Program") as required by Rule 22e-4 (the "Liquidity Rule") under the 1940 Act. The Program is reasonably designed to assess and manage the Fund's liquidity risk, taking into consideration, among other factors, the Fund's investment strategy and the liquidity of its portfolio investments during normal and reasonably foreseeable stressed conditions; its short and long-term cash flow projections; and its cash holdings and access to other funding sources. The Fund's Board has approved the appointment of the Liquidity Program Administrator, comprising certain employees of the Adviser. The Liquidity Program Administrator maintains Program oversight and reports to the Board on at least an annual basis regarding the Program's operational effectiveness through a written report (the "Report"). The Program's most recent Report outlined the operation of the Program and the adequacy and effectiveness of the Program's implementation. During the review period, the Fund's holdings in securities that are deemed illiquid assets was approximately 0% of its net assets, with less than liquid securities at approximately 4.7% of net assets. Also, during the review period the Fund held adequate levels of cash and highly liquid investments to meet shareholder redemption activities in accordance with applicable requirements. The Report concluded that (i) the Program is reasonably designed to prevent violation of the Liquidity Rule and (ii) the Program has been effectively implemented.

**Privacy Policy**

The following is a description of the Fund's policies regarding disclosure of nonpublic personal information that you provide to the Fund or that the Fund collects from other sources. In the event that you hold shares of the Fund through a broker-dealer or other financial intermediary, the privacy policy of your financial intermediary would govern how your nonpublic personal information would be shared with unaffiliated third parties.

**Categories of Information the Fund Collects.** The Fund collects the following nonpublic personal information about you:

● Information the Fund receives from you on or in applications or other forms, correspondence, or conversations (such as your name, address, phone number, social security number, assets, income and date of birth); and

● Information about your transactions with the Fund, or others (such as your account number and balance, payment history, parties to transactions, cost basis information, and other financial information).

**Categories of Information the Fund Discloses.** The Fund does not disclose any nonpublic personal information about its current or former shareholders to unaffiliated third parties, except as required or permitted by law. The Fund is permitted by law to disclose all of the information it collects, as described above, to its service providers (such as the Fund's custodian, administrator and transfer agent) to process your transactions and otherwise provide services to you.

**Confidentiality and Security.** The Fund restricts access to your nonpublic personal formation to those persons who require such information to provide products or services to you. The Fund maintains physical, electronic and procedural safeguards that comply with federal standards to guard your nonpublic personal information.

**Disposal of Information.** The Fund, through its transfer agent, has taken steps to reasonably ensure that the privacy of your nonpublic personal information is maintained at all times, including in connection with the disposal of information that is no longer required to be maintained by the Fund. Such steps shall include whenever possible, shredding paper documents and records prior to disposal, requiring off-site storage vendors to shred documents maintained in such locations prior to disposal, and erasing and/or obliterating any data contained on electronic media in such a manner that the information can no longer be read or reconstructed.

*This page is intentionally left blank.*

**Proxy Voting**

A description of the policies and procedures that the Fund uses to determine how to vote proxies relating to portfolio securities and information regarding how the Fund voted those proxies during the most recent twelve month period ended June 30, are available (1) without charge upon request by calling the Fund at (800) 872-7823 and (2) in Fund documents filed with the Securities and Exchange Commission ("SEC") on the SEC's website at www.sec.gov.

---

| |
|:---|
| **BRUCE FUND** |
| **OFFICERS AND DIRECTORS** |
| **Robert B. Bruce** |
| *President, Treasurer and Director* |
| **R. Jeffrey Bruce** |
| *Vice President and Secretary* |
| **Robert DeBartolo** |
| *Director* |
| **W. Martin Johnson** |
| *Director* |
| **Investment Adviser** |
| Bruce & Co., Inc. |
| Chicago, Illinois |
| **Custodian** |
| Huntington National Bank |
| Columbus, Ohio |
| **Administrator, Transfer Agent and Fund Accountant** |
| Ultimus Fund Solutions, LLC |
| Cincinnati, Ohio |
| **Distributor** |
| Ultimus Fund Distributors, LLC |
| Cincinnati, Ohio |
| **Counsel** |
| Klevatt & Associates |
| Chicago, Illinois |
| **Independent Registered Public Accounting Firm** |
| Grant Thornton LLP |
| Chicago, Illinois |

---

This report is intended only for the information of shareholders or those who have received the Fund's prospectus which contains information about the Fund's management fees and expenses. Please read the prospectus carefully before investing.

Distributed by Ultimus Fund Distributors, LLC, Member FINRA/SIPC

Bruce-SAR-22

(b) Not applicable.

**Item 2. Code of Ethics.** 

Not applicable

**Item 3. Audit Committee Financial Expert.** 

Not applicable

**Item 4. Principal Accountant Fees and Services.** 

Not applicable

**Item 5. Audit Committee of Listed Companies.** 

Not applicable

**Item 6. Schedule of Investments.** 

Not applicable – schedule filed with Item 1.

**Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.**

Not Applicable - Applies to closed-end funds only.

**Item 8. Portfolio Managers of Closed-End Management Investment Companies.** 

Not applicable - Applies to closed-end funds only.

**Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.** 

Not applicable - Applies to closed-end funds only.

**Item 10. Submission of Matters to a Vote of Security Holders.** 

Not Applicable - The registrant has not adopted procedures by which shareholders may recommend nominees to the registrant's board of directors.

**Item 11. Controls and Procedures.**

(a) The registrant's Principal Executive Officer and Principal Financial Officer have concluded that the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Act) are effective in design and operation and are sufficient to form the basis of the certifications required by Rule 30a-2 under the Act, based on their evaluation of these disclosure controls and procedures within 90 days of the filing of this report on Form N-CSR.

(b) There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d))) that occurred during the period covered by this report that have materially affected or are reasonably likely to materially affect, the registrant's internal control over financial reporting.

**Item 12. Disclosure of Securities Lending Activities for Closed-End Investment Companies.**

Not Applicable.

**Item 13. Exhibits.** 

(a)(1) Not applicable – Filed with Annual Report

(a)(2) [Certifications by the registrant's principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes- Oxley Act of 2002 and required by Rule 30a-2under the Investment Company Act of 1940 are filed herewith.](cert1.htm)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Not applicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Change in registrant's independent public accountants: Not applicable

(a)(3) Not Applicable – there were no written solicitations to purchase securities under Rule 23c-1

during the period.

(b) [Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 is filed herewith.](cert2.htm)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant) Bruce Fund

---

| | |
|:---|:---|
| &nbsp;&nbsp;By | &nbsp;&nbsp;/s/ Robert B. Bruce |
|  | &nbsp;&nbsp;Robert B. Bruce, President |

---

Date <u>2/17/2023</u>

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| &nbsp;&nbsp;By | &nbsp;&nbsp;/s/ Robert B. Bruce |
|  | &nbsp;&nbsp;Robert B. Bruce, President |

---

Date <u>2/17/2023</u>

---

| | |
|:---|:---|
| &nbsp;&nbsp;By | &nbsp;&nbsp;/s/ R. Jeffrey Bruce |
|  | &nbsp;&nbsp;R. Jeffery Bruce, Principal Accounting Officer |

---

Date <u>2/17/2023</u>

## Ex-99.Cert

**Exhibit99.CERT**

**<u>Form N-CSR Certification</u>**

I, Robert B. Bruce, certify that:

1. I have reviewed this report on Form N-CSR of Bruce Fund, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the
financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this
report;

4. The other certifying officers and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as
defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented
in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to
the filing date of this report, based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting
that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The other certifying officers and I have disclosed, based on our most recent evaluations, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies in the design or operation of internal controls which could adversely affect
the registrant's ability to record, process, summarize, and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant's internal controls; and

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;2/17/2023 | &nbsp;&nbsp;/s/ Robert B. Bruce |
|  |  | &nbsp;&nbsp;Robert B. Bruce |
|  |  | &nbsp;&nbsp;President |

---

**<u>Form N-CSR Certification</u>**

I, R. Jeffrey Bruce, certify that:

1. I have reviewed this report on Form N-CSR of Bruce Fund, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the
financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this
report;

4. The other certifying officers and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as
defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented
in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to
the filing date of this report, based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting
that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The other certifying officers and I have disclosed, based on our most recent evaluations, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies in the design or operation of internal controls which could adversely affect
the registrant's ability to record, process, summarize, and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant's internal controls; and

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Date: | &nbsp;&nbsp;2/17/2023 | &nbsp;&nbsp;/s/ R. Jeffrey Bruce |
|  |  | &nbsp;&nbsp;R. Jeffrey Bruce |
|  |  | &nbsp;&nbsp;Principal Accounting Officer |

---

## Exhibit 99.906

EX-99.906CERT

**certification**

Robert B. Bruce, President, and R. Jeffrey Bruce, Principal Accounting Officer of Bruce Fund, Inc. (the "Registrant"), each certify to the best of his or her knowledge that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Registrant's periodic report on Form N-CSR for the period ended December 31, 2022 (the "Form N-CSR") fully complies with the requirements of Sections 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

President Principal Accounting Officer

Bruce Fund, Inc. Bruce Fund, Inc.

---

| | |
|:---|:---|
| &nbsp;&nbsp;/s/ Robert B. Bruce | &nbsp;&nbsp;/s/ R. Jeffrey Bruce |
| &nbsp;&nbsp;Robert B. Bruce | &nbsp;&nbsp;R. Jeffrey Bruce |

---

Date: <u>2/17/2023</u> Date: <u>2/17/2023</u>

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Bruce Fund, Inc. and will be retained by Bruce Fund, Inc. and furnished to the Securities and Exchange Commission (the "Commission") or its staff upon request.

This certification is being furnished to the Commission solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Form N-CSR filed with the Commission.